Metabolic effects of intranasally administered glucagon: Comparison with intramuscular and intravenous injection
Summary
Intranasal administration of glucagon, 1 mg, plus sodium glycocholate 15 mg as a surfactant, raised blood glucose levels and plasma levels of immunoreactive glucagon (IRG) and immunoreactive insulin (IRI). Spray solutions were more effective than drops, and neither the surfactant alone nor glucagon alone had any effect. Blood glucose levels were similarly affected by intravenous glucagon, while intramuscular glucagon was slightly more effective. The highest IRG concentrations were reached after intravenous administration, while intramuscular injection of glucagon was accompanied by the highest IRI release. These data indicate that intranasal administration of glucagon exerts metabolic effects similar to intramuscular and intravenous administrations. Further studies are needed to improve bioavailability and efficacy of intranasally administered glucagon.
Key-words
Glucagon Hypoglycemia Intramuscular Intranasal Intravenous Nose SprayPreview
Unable to display preview. Download preview PDF.
References
- 1.Baumann G., Walser A., Desaulles P. A., Paesi F. J. A., Geller L.: Corticotropin action of an intranasally applied synthetic ACTH derivate — J. clin. Endocrinol.42, 63, 1976.Google Scholar
- 2.Benson J. W., Johnson D. G., Palmer J. P., Werner P. L., Ensinck J. W.: Glucagon and catecholamines secretion during hypoglycaemia in normal and diabetic man — J. clin. Endocrinol.44, 459, 1977.CrossRefGoogle Scholar
- 3.Cochrane W. G., Cox G. M.: Incomplete block designs. 2nd Ed., Chapter 9. J. Wiley and Sons, New York, 1957; p. 376.Google Scholar
- 4.Crane C. W., Path M. C., Luntz G. R. V.: Absorption of insulin from the human intestine — Diabetes17, 625, 1968.PubMedGoogle Scholar
- 5.Fink G., Gennser G., Liedholm P., Thorell J.: Comparison of plasma levels of LHRH in man after intravenous and intranasal administration — J. clin. Endocrinol.63, 351, 1974.Google Scholar
- 6.Leaf A., Coggins C. H.: The neurohypophysis. In:Williams R. H. (Ed.): Textbook of endocrinology. 5th Ed. W.B. Saunders, Philadelphia, 1974; p. 80.Google Scholar
- 7.Moses A. C., Gordon G. S., Carey M. C., Flier J. S.: Insulin administered intranasally as an insulin-bile salt aerosol. Effectiveness and reproducibility in normal and diabetic subjects — Diabetes32, 1040, 1983.PubMedCrossRefGoogle Scholar
- 8.Pontiroli A. E., Alberetto M., Pozza G.: Intranasal glucagon raises blood glucose concentration in healthy volunteers — Brit. med. J.ii, 462, 1983.Google Scholar
- 9.Pontiroli A. E., Alberetto M., Secchi A., Dossi G., Bosi I., Pozza G.: Insulin given intranasally induces hypoglycaemia in normal and diabetic subjects — Brit. med. J.i, 303, 1982.CrossRefGoogle Scholar